DEVELOPMENT AND EVALUATION OF CYCLODEXTRIN NANOSPONGES BASED TOPICAL FORMULATION OF TAZAROTENE

RAVINDRA PRATAP; SRINIVAS LANKALAPALLI

doi:10.22159/ijap.2024v16i6.51926

Authors

RAVINDRA PRATAP Gitam School of Pharmacy, Gitam Deemed To Be University, Rushikonda, Visakhapatnam-530045, Andhra Pradesh, India https://orcid.org/0009-0000-2222-0117
SRINIVAS LANKALAPALLI Gitam School of Pharmacy, Gitam Deemed To Be University, Rushikonda, Visakhapatnam-530045, Andhra Pradesh, India https://orcid.org/0000-0003-3834-8988

DOI:

https://doi.org/10.22159/ijap.2024v16i6.51926

Keywords:

Tazarotene, Retinoids, Nanosponges, Carbopol-946, Diffusion

Abstract

Objective: Tazarotene is used as topical retinoid for the treatment of acne, psoriasis and sun damaged skin. But its topical formulation has many side-effects including itching, burning, dryness, redness, stinging, rash blistering, skin discolouration, peeling at the site of application and low bioavailability. The present study focuses on the reduction of side effects and enhancement of solubility and topical bioavailability of tazarotene by using cyclodextrin based nanosponges.

Methods: Nanosponge of tazarotene were prepared by lyophilization method. The physiochemical characterization of plain nanosponges and drug loaded nanosponges were performed using Fourier Transform Infrared Spectroscopy (FTIR), Differential Scanning Calorimetry (DSC), and X-ray Diffractometer (XRD) studies. The drug loaded nanosponges were incorporated into a carbopol based gel formulation. The prepared formulation was evaluated for viscosity, dissolution and stability. FTIR, DSC and XRD studies confirmed the formation of inclusion complex of tazarotene with nanosponges .

Results: The particle size of the drug loaded nanosponges was found to be in the range of 156.72 to 163.48 nm. Transmission Electron Microscopy (TEM) images revealed the regular spherical shape of both the nanosponges that are unaffected even after drug encapsulation. The pH of the gel formulations was found to be in the range of 5.86 to 6.46. The gel formulation resulted in the diffusion of drug in controlled manner for up to 24 h. The in-vitro dissolution studies revealed that nanosponges based topical formulation had better results than the marketed product.

Conclusion: Thus, the study showed that nanosponge based gel formulation can be a possible alternative to conventional formulations of tazarotene with enhanced bioavailability and skin retention characteristics for topical application

Downloads

Download data is not yet available.

References

Billi AC, Gudjonsson JE, Voorhees JJ. Psoriasis: past, present, and future. The Journal of investigative dermatology. 2019 Nov;139(11):e133. http://dx.doi.org/10.1016/j.jid.2019.08.437.

Kassir M, Karagaiah P, Sonthalia S, Katsambas A, Galadari H, Gupta M, Lotti T, Wollina U, Abdelmaksoud A, Grabbe S, Goldust M. Selective RAR agonists for acne vulgaris: A narrative review. Journal of cosmetic dermatology. 2020 Jun;19(6):1278-83. https://doi.org/10.1111/jocd.13340.

Torsekar R, Gautam MM. Topical therapies in psoriasis. Indian dermatology online journal. 2017 Jul 1;8(4):235-45. https://doi.org/10.4103/2229-5178.209622.

Huang, WW., Ahn, CS. General dermatology. Clinical Manual of Dermatology. 2020; 31-152. Springer, Cham. https://doi.org/10.1007/978-3-030-23940-4.

Zhu Z, Liu Y, Xue Y, Cheng X, Zhao W, Wang J, He R, Wan Q, Pei X. Tazarotene released from aligned electrospun membrane facilitates cutaneous wound healing by promoting angiogenesis. ACS applied materials & interfaces. 2019 Sep 10;11(39):36141-53. https://doi.org/10.1021/acsami.9b13271.

Zen AA, Nawrot DA, Howarth A, Caporali A, Ebner D, Vernet A, Schneider JE, Bhattacharya S. The retinoid agonist tazarotene promotes angiogenesis and wound healing. Molecular Therapy. 2016 Oct 1;24(10):1745-59. https://doi.org/10.1038/mt.2016.153.

Fox L, Csongradi C, Aucamp M, Du Plessis J, Gerber M. Treatment modalities for acne. Molecules. 2016 Aug 13;21(8):1063. https://doi.org/10.3390/molecules21081063.

Cosio T, Gaziano R, Zuccari G, Costanza G, Grelli S, Di Francesco P, Bianchi L, Campione E. Retinoids in fungal infections: From bench to bedside. Pharmaceuticals. 2021 Sep 24;14(10):962. https://doi.org/10.3390/ph14100962.

Sidgiddi S, Allenby K, Okumu F, Gautam A. Bioavailability, pharmacokinetics, and transepidermal water loss of short contact tazarotene lotion 0.1% versus tazarotene (Tazorac®) cream 0.1%. The Journal of Clinical and Aesthetic Dermatology. 2019 Sep;12(9):16. https://www.ncbi.nlm.nih.gov › articles › PMC6777703.

Gregoriou S, Kritsotaki E, Katoulis A, Rigopoulos D. Use of tazarotene foam for the treatment of acne vulgaris. Clinical, cosmetic and investigational dermatology. 2014 May 27:165-70. https://doi.org/10.2147/CCID.S37327.

Mahé E, Amy De la Breteque M, Phan C. Perspectives on the pharmacological management of psoriasis in pediatric and adolescent patients. Expert Review of Clinical Pharmacology. 2021 Jul 3;14(7):807-19. https://doi.org/10.1080/17512433.2021.1911641.

Otlewska A, Baran W, Batycka-Baran A. Adverse events related to topical drug treatments for acne vulgaris. Expert Opinion on Drug Safety. 2020 Apr 2;19(4):513-21. https://doi.org/10.1080/14740338.2020.1757646.

Vyas A, Kumar Sonker A, Gidwani B. Carrier‐based drug delivery system for treatment of acne. The scientific world journal. 2014;2014(1):276260. https://doi.org/10.1155/2014/276260.

Latter G, Grice JE, Mohammed Y, Roberts MS, Benson HA. Targeted topical delivery of retinoids in the management of acne vulgaris: current formulations and novel delivery systems. Pharmaceutics. 2019 Sep 24;11(10):490. https://doi.org/10.3390/pharmaceutics11100490.

Prasad V, Chaurasia S. Performance evaluation of non-ionic surfactant based tazarotene encapsulated proniosomal gel for the treatment of psoriasis. Materials Science and Engineering: C. 2017 Oct 1;79:168-76. https://doi.org/10.1016/j.msec.2017.05.036.

Patel MR, Patel RB, Parikh JR, Patel BG. Novel microemulsion-based gel formulation of tazarotene for therapy of acne. Pharmaceutical development and technology. 2016 Nov 16;21(8):921-32. https://doi.org/10.3109/10837450.2015.1081610.

Kumar S, Dalal P, Rao R. Cyclodextrin nanosponges: a promising approach for modulating drug delivery. Colloid science in pharmaceutical nanotechnology. 2020 Feb 12;79.

Anandam S, Selvamuthukumar S. Optimization of microwave-assisted synthesis of cyclodextrin nanosponges using response surface methodology. Journal of Porous Materials. 2014 Dec;21:1015-23. https://doi.org/10.1007/s10934-014-9851-2.

Kumar S, Prasad M, Rao R. Topical delivery of clobetasol propionate loaded nanosponge hydrogel for effective treatment of psoriasis: Formulation, physicochemical characterization, antipsoriatic potential and biochemical estimation. Materials Science and Engineering: C. 2021 Feb 1;119:111605. https://doi.org/10.1016/j.msec.2020.111605.

Selvamuthukumar S, Anandam S, Krishnamoorthy K, Rajappan M. Nanosponges: A novel class of drug delivery system-review. Journal of Pharmacy & Pharmaceutical Sciences. 2012 Jan 17;15(1):103-11. https://doi.org/10.18433/j3k308.

Ahmed MM, Fatima F, Anwer MK, Ibnouf EO, Kalam MA, Alshamsan A, Aldawsari MF, Alalaiwe A, Ansari MJ. Formulation and in vitro evaluation of topical nanosponge-based gel containing butenafine for the treatment of fungal skin infection. Saudi Pharmaceutical Journal. 2021 May 1;29(5):467-77. https://doi.org/10.1016/j.jsps.2021.04.010.

Conte C, Caldera F, Catanzano O, D'Angelo I, Ungaro F, Miro A, Pellosi DS, Trotta F, Quaglia F. β-cyclodextrin nanosponges as multifunctional ingredient in water-containing semisolid formulations for skin delivery. Journal of pharmaceutical sciences. 2014 Dec 1;103(12):3941-9. https://doi.org/10.1002/jps.24203.

Singireddy A, Pedireddi SR, Subramanian S. Optimization of reaction parameters for synthesis of Cyclodextrin nanosponges in controlled nanoscopic size dimensions. Journal of Polymer Research. 2019 Apr;26:1-2. https://doi.org/10.1007/s10965-019-1754-0

Pedireddi S, Singireddy A, Varma MM, Jayanthi VR. Differential Properties of Nanoporous Nanosponges Prepared from β-Cyclodextrin and 2-Hydroxypropyl β-Cyclodextrin. Advanced Science, Engineering and Medicine. 2019 Sep 1;11(9):823-35. https://doi.org/10.1166/asem.2019.2423.

Singireddy A, Subramanian S. Cyclodextrin nanosponges to enhance the dissolution profile of quercetin by inclusion complex formation. Particulate science and technology. 2016 May 3;34(3):341-6. https://doi.org/10.1080/02726351.2015.1081658.

Singireddy A, Pedireddi SR, Nimmagadda S, Subramanian S. Beneficial effects of microwave assisted heating versus conventional heating in synthesis of cyclodextrin based nanosponges. Materials Today: Proceedings. 2016 Jan 1;3(10):3951-9. https://doi.org/10.1016/j.matpr.2016.11.055.

Verma P, Pathak K. Nanosized ethanolic vesicles loaded with econazole nitrate for the treatment of deep fungal infections through topical gel formulation. Nanomedicine: Nanotechnology, Biology and Medicine. 2012 May 1;8(4):489-96. https://doi.org/10.1016/j.nano.2011.07.004.

Bachhav YG, Patravale VB. Microemulsion based vaginal gel of fluconazole: formulation, in vitro and in vivo evaluation. International Journal of Pharmaceutics. 2009 Jan 5;365(1-2):175-9. https://doi.org/10.1016/j.ijpharm.2008.08.021.

Ellaithy HM, El-Shaboury KM. The development of Cutina lipogels and gel microemulsion for topical administration of fluconazole. Aaps Pharmscitech. 2002 Feb;3:77-85. https://doi.org/10.1208/pt030435.

Son GH, Lee BJ, Cho CW. Mechanisms of drug release from advanced drug formulations such as polymeric-based drug-delivery systems and lipid nanoparticles. Journal of Pharmaceutical Investigation. 2017 Jul;47:287-96. https://doi.org/10.1007/s40005-017-0320-1

Lin YK, Yang SH, Chen CC, Kao HC, Fang JY. Using imiquimod-induced psoriasis-like skin as a model to measure the skin penetration of anti-psoriatic drugs. PLoS One. 2015 Sep 10;10(9):e0137890. https://doi.org/10.1371/journal.pone.0137890.

Neves, AR., Queiroz, JF., Lima, SA., Figueiredo, F., Fernandes, R., Reis, S. 2016. "Cellular uptake and transcytosis of lipid-based nanoparticles across the intestinal barrier: relevance for oral drug delivery." Journal of colloid and interface science. 463:258-65. https://doi.org/10.1016/j.jcis.2015.10.057.

Queiroz JF, Lima SA, Figueiredo F, Fernandes R, Reis S. Cellular uptake and transcytosis of lipid-based nanoparticles across the intestinal barrier: relevance for oral drug delivery. Journal of colloid and interface science. 2016 Feb 1;463:258-65. https://doi.org/10.1016/j.jcis.2015.10.057.

Anandam S, Selvamuthukumar S. Fabrication of cyclodextrin nanosponges for quercetin delivery: physicochemical characterization, photostability, and antioxidant effects. Journal of materials science. 2014 Dec;49:8140-53. https://doi.org/10.1007/s10853-014-8523-6.

Cascone S, Lamberti G. Hydrogel-based commercial products for biomedical applications: A review. International journal of pharmaceutics. 2020 Jan 5;573:118803. https://doi.org/10.1016/j.ijpharm.2019.118803.

Verma P, Pathak K. Nanosized ethanolic vesicles loaded with econazole nitrate for the treatment of deep fungal infections through topical gel formulation. Nanomedicine: Nanotechnology, Biology and Medicine. 2012 May 1;8(4):489-96. https://doi.org/10.1016/j.nano.2011.07.004